BrightInsight, a leading platform for biopharma digital health solutions, announced its integration of Google Cloud's AI technologies, including Gemini and MedLM generative AI models, to enhance its research and development and improve its Disease Management Solution. This integration, facilitated through Google's Vertex AI platform, aims to streamline R&D processes, enrich patient engagement with AI-driven chatbots, and enable efficient data analysis for healthcare providers.
The new AI enhancements will allow BrightInsight to offer real-time, personalised support to patients and gather unique insights from therapy and app usage data. These capabilities are designed to improve disease management, make medical information more accessible to patients, and support clinicians by providing actionable insights from patient data, thus facilitating more informed healthcare decisions.
BrightInsight is committed to maintaining high standards of security, privacy, and compliance, and its AI integrations follow these stringent protocols, including HIPAA and GDPR compliance through Google Cloud's secure infrastructure. This collaboration underscores BrightInsight's ongoing commitment to leveraging cutting-edge technology to transform patient outcomes in the healthcare sector.
Click here to read the original news story.